Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nimish S. Narkar"'
Autor:
Teja Deshpande, Revati Kothari, Nimish S. Narkar, Harshavardhan Bhide, Anita Barde, A. V. Tilak
Publikováno v:
Journal of Pharmaceutical Research International. :510-517
Background: Antibiotic resistance is exponentially increasing worldwide. Irrational prescription of antibiotic treatment contributes to the development of antibiotic resistance. Appropriate antibiotic use is vital in reducing the mortality caused by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46f639d00b07cbfa7d7ac69fa68c5bed
https://doi.org/10.9734/jpri/2021/v33i43b32582
https://doi.org/10.9734/jpri/2021/v33i43b32582
Autor:
Teja Deshpande, B. T. Rane, Nimish S. Narkar, Harshavardhan Bhide, A. V. Tilak, Revati Kothari
Publikováno v:
Biomedical and Pharmacology Journal. 14:961-969
Hypertension is a leading cause of cardiovascular morbidity and mortality. Although known as disease of old age, younger population is at increasing risk due to various factors including obesityand diabetes. Antihypertensive drug treatment being the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a84f57305993a508f4b3fa29505e5919
https://doi.org/10.13005/bpj/2197
https://doi.org/10.13005/bpj/2197
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 9:934
Background: Teneligliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor, available in India. It has been widely prescribed in type 2 diabetes mellitus (T2 DM) due to its low cost. However, there are few studies comparing it with other DPP-4 inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c32285cec9887dcfb8d0d0ee4557d62
https://doi.org/10.18203/2319-2003.ijbcp20202192
https://doi.org/10.18203/2319-2003.ijbcp20202192
Autor:
Siddhi Raveendran, Pratik Rane, Sanjeevani Chaware, Sayan Das, Nimish S. Narkar, Abhijeet V. Tilak
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 8:925
Background: Diabetes mellitus (DM) can be defined as chronic hyperglycemia due to lack in insulin secretion and/or action. This study was designed to compare the antidiabetic activity of Coriandrum sativum L. with the standard antidiabetic drug, Metf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0099becf85015a661736a353d4d5a5a9
https://doi.org/10.18203/2319-2003.ijbcp20191577
https://doi.org/10.18203/2319-2003.ijbcp20191577